When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis by Prince FHM, Twilt M, Simon SCM, van Rossum MAJ, Armbrust W, Hoppenreijs EPAH, Kamphuis SSM, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat N, ten Cate R, van Suijlekom-Smit LWA

Association of the <it>CCR5</it>Δ32 variant with juvenile idiopathic arthritis in a meta-analysis by Toes REM, Houwing-Duistermaat JJ, Saurenmann RK, Wouters C, Girschick HJ, Hoppenreijs EPAH, van Rossum MAJ, Kamphuis SSM, Brinkman DMC, Albers HM, Reinards THCM, Huizinga TWJ, ten Cate R, Schilham MW

Etanercept in juvenile idiopathic arthritis: Who will benefit? by van den Berg JM, Swart JF, Dolman KM, Gorter SL, Koopman-Keemink Y, Twilt M, Hoppenreijs EPAH, ten Cate R, Armbrust W, Prince FHM, Otten MH, Wulffraat NM, van Rossum MAJ, van Suijlekom-Smit LWA